Science Explorer Back to mapMap
Discussion
Researcher · Innsbruck Medical University · Austria

Harald Hegen

Harald Hegen publishes mostly in Pathology and Forensic Medicine, Neurology and Rheumatology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Polyomavirus and related diseases.

ORCID 0000-0002-2833-6337 OpenAlex
World rank
#302,254
of 7,710,434 ranked researchers
Rank in Austria
#2,141
of 43,330
Works
243
Citations
5.9k
Citations per work
24.2
h-index
38
i10-index 108Top 8.6% in Pathology and Forensic Medicine
Harald Hegen

What does Harald Hegen research?

Harald Hegen's work is mostly in Medicine (60%), Immunology and Microbiology (3%).

Health Sciences: 146 works · 60.0% of their workMedicine: 146 works · 60.0% of their workPathology and Forensic Medicine: 62 works · 25.6% of their workNeurology: 52 works · 21.2% of their workRheumatology: 14 works · 5.6% of their workOncology: 11 works · 4.4% of their workOphthalmology: 8 works · 3.2% of their workEverything else: 89 works · 36.8% of their workLife Sciences: 8 works · 3.2% of their workImmunology and Microbiology: 8 works · 3.2% of their workImmunology: 8 works · 3.2% of their workTHEIR WORKHarald Hegen243works
Life Sciences3%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine14660.0%
  2. Everything else8936.8%
    1. Immunology and Microbiology83.2%
  1. 1Pathology and Forensic Medicine26% of their works
  2. 2Neurology21% of their works
  3. 3Rheumatology6% of their works
  4. 4Oncology4% of their works
  5. 5Ophthalmology3% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Harald Hegen's research?

The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Neurological Disorders, Treatment, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Guillain-Barré Syndrome.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Cognitive Impairment1863 topics
  2. Diagnostic Criteria1712 topics
  3. Multiple Sclerosis1551 topic
  4. Neuromyelitis Optica1551 topic
  5. Neurological Disorders1033 topics
  6. Treatment852 topics
  7. Chronic Inflammatory Demyelinating Polyradiculoneuropathy721 topic
  8. Guillain-Barré Syndrome721 topic
  9. Autoantibodies533 topics
  10. Antiphospholipid Syndrome241 topic
  11. Merkel Cell Carcinoma241 topic
  12. Polyomavirus241 topic
  13. Systemic Lupus Erythematosus241 topic
  14. Anti-NMDA Receptor Encephalitis161 topic
  15. Paraneoplastic Syndromes161 topic
  16. Cerebrospinal Fluid151 topic
  17. Glymphatic System151 topic
  18. Neurologic Manifestations151 topic
  19. Post-acute COVID-19 Syndrome151 topic
  20. Fibrosis131 topic
  21. Systemic Sclerosis131 topic

Where does Harald Hegen work?

Harald Hegen's main affiliation in the publication record is Innsbruck Medical University, Austria.

How many publications and citations does Harald Hegen have?

OpenAlex counts 243 works and 5,879 citations for Harald Hegen, an h-index of 38, ranking #302,254 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Harald Hegen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.